We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

News · May 25, 2022

ATS 2022: Mortality Rate Reduced for COVID-19 Patients Treated With Imatinib Versus Placebo

Patients treated with imatinib also had shorter duration of invasive ventilation and shorter stays in ICU

PracticeUpdate Editorial Team

 

Further Reading